查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
人工智能在癌症诊断中的全球市场规模、份额和行业趋势分析报告：2022-2028 年最终用户、成分、癌症类型、地区的展望和预测
市场调查报告书
商品编码
1172713

人工智能在癌症诊断中的全球市场规模、份额和行业趋势分析报告：2022-2028 年最终用户、成分、癌症类型、地区的展望和预测

Global AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user, By Component, By Cancer Type, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 228 Pages | 订单完成后即时交付

价格

在预测期内，人工智能在癌症诊断领域的全球市场规模预计将以 28.6% 的复合年增长率增长，到 2028 年将达到 5.09 亿美元。

此外，这些算法不断更新，并通过接触新数据获得信息。 深度学习与机器学习和人工智能一起用于癌症检测。 它还利用模拟人脑如何收集、分析和响应来自全身的信号的人工神经网络。 NCI 校内研究计划的研究人员正在利用 AI 的全部力量来加强对前列腺癌和宫颈癌的癌症筛查。

15 年前，NCI 的医生开始使用 MRI 活检来帮助研究人员瞄准可能癌变的前列腺区域。 MRI 活检增强了前列腺癌专业人员的检测和治疗。 此外，人工智能不仅记录了临床医生的诊断技能，还让全国各地的诊所都可以使用算法来辅助临床诊断和决策。

COVID-19 影响分析

冠状病毒对癌症诊断领域的 AI 市场产生了积极影响。 人工智能和机器学习的引入有助于减轻医疗机构和临床设施的工作量。 随着该行业的发展，许多国际 IT 巨头已着手开发人工智能工具和软件来识别冠状病毒，然后帮助检测癌症症状。 由于冠状病毒患者导致医疗保健专业人员短缺，这将推动人工智能解决方案的采用，以提供更好的患者支持和结果。 诊断、善后护理和其他程序在大流行期间很难维持，因为它们非常耗时。

市场增长因素

医疗保健领域技术进步的增加

在检测癌症诊断方面采用技术和人工智能将推动医疗保健行业的发展。 人工工具包括对低成本诊断程序和快速检测数据生成的需求。 此外，医疗保健领域对癌症检测和筛查技术开发的需求预计将支持该行业的增长。 此外，用于加强医疗保健技术的政府支出正在推动新兴国家医疗保健行业的增长。

对早期癌症诊断的需求不断增长

人们对早期癌症诊断意识的提高正在推动 AI 在癌症诊断中的发展。 与医疗机构一起，越来越多的政府计划鼓励医护人员将 AI 技术整合到医院，以改善患者和提高治疗水平。 此外，技术的采用将帮助私人和非营利组织提供更好的医疗结果并降低治疗成本，从而增加人群的早期诊断。

市场製约因素

对人工智能在医疗领域的应用缺乏了解

除了人工智能係统和机器学习的知识和培训，管理庞大的数据集和数据库是深度学习技术的最大障碍。 然而，人工智能的使用也会带来数据洩露问题，因为它可以提供重要的个人数据，例如基因组序列。 限制增长的各种问题包括缺乏透明度、AI 算法偏差的风险、用于学习目的的数据以及临床环境中 AI 采用权威的新问题。 哲学问题是人工智能面临的最困难的问题之一。

最终用户视角

按终端用户划分，癌症诊断领域的 AI 市场分为医院、手术中心和医疗机构等。 2021 年，外科中心和医疗机构部门在癌症诊断的 AI 市场中占据了显着的收入份额。 人工智能的采用减少了误导性的阴性和阳性病例，并提供了更可靠的患者治疗结果。 随着医疗保健的发展，医学教育也在不断发展。 此外，通过实施 AI 和利用数据学习实现更好的发明来采用和实践医疗保健将促进行业增长和决策。

组件视角

基于组件，癌症诊断中的人工智能市场被细分为软件解决方案、硬件和服务。 软件解决方案部分在 2021 年的癌症诊断 AI 市场中获得了最高的收入份额。 这是因为许多大型竞争对手正在推出新的癌症诊断解决方案。 借助软件，医生可以高效、准确地识别癌症和肿瘤的微小尺寸。 此外，人工智能软件比人类诊断系统更准确、更可靠。 该软件平台提供高质量的分析和快速的结果，增加了医生的信心，提高了工作效率和人身安全。

癌症类型的前景

癌症诊断的人工智能市场根据癌症类型分为乳腺癌、肺癌、前列腺癌/结直肠癌、脑癌、皮肤癌/宫颈癌等。 2021 年，乳腺癌细分市场在癌症诊断的 AI 市场中获得了最大的收入份额。 因为乳腺中的细胞失控，乳腺癌的发病率越来越高。 乳腺癌取决于作为癌症出现的乳房中的哪些细胞被感染。 乳房由导管、小叶和结缔组织三部分组成。

区域展望

按地区划分，对北美、欧洲、亚太地区和 LAMEA 的癌症诊断市场中的 AI 进行了分析。 北美市场将在 2021 年占据癌症诊断 AI 市场的最大收入份额。 癌症患病率的增加以及现代医疗基础设施的可及性正在推动市场增长。 然而，政府在医疗保健领域的举措和支出的增加将推动人工智能在医疗保健领域的发展。 越来越多的患者诊断将推动人工智能在该地区癌症诊断领域的发展。

合作伙伴关係是市场进入者采取的主要策略。 根据基数矩阵中的分析，Microsoft Corporation是癌症诊断领域的 AI 市场先驱。 Flatiron Health（F. Hoffmann-La Roche Ltd.）、Paige AI, Inc.、PathAI, Inc. 等公司是癌症诊断人工智能市场的主要创新者。

内容

第一章市场范围与研究方法

  • 市场定义
  • 目的
  • 市场规模
  • 细分
    • 全球 AI 癌症诊断市场，按最终用户分类
    • 癌症诊断中 AI 的全球市场，按组件分类
    • 全球癌症诊断人工智能市场（按癌症类型）
    • 全球 AI 癌症诊断市场，按地区划分
  • 调查方法

第 2 章市场概述

  • 简介
    • 简介
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动因素
    • 市场製约因素

第 3 章竞争分析 - 世界

  • KBV 基数矩阵
  • 近期的全行业战略发展
    • 伙伴关係、协作和合同
    • 产品发布和产品扩展
    • 收购与合併
  • 关键成功策略
    • 主要领先战略：比例分布（2018-2022 年）
    • 关键战略举措：（伙伴关係、协作、合同：2019 年 12 月至 2022 年 11 月）主要参与者

第 4 章 AI 在癌症诊断中的全球市场：按最终用户分类

  • 全球医院市场：按地区
  • 按地区划分的全球外科中心和医疗机构市场
  • 世界其他地区市场

第 5 章 AI 在癌症诊断中的全球市场：按组件分类

  • 全球软件解决方案市场：按地区
  • 全球硬件市场：按地区
  • 按地区划分的全球服务市场

第 6 章人工智能在癌症诊断中的全球市场：按癌症类型分类

  • 按地区划分的世界乳腺癌市场
  • 全球肺癌市场：按地区
  • 全球脑肿瘤市场：按地区
  • 按地区划分的皮肤癌和宫颈癌市场
  • 按地区划分的全球前列腺癌和结直肠癌市场
  • 世界其他地区的世界市场

第 7 章。全球癌症诊断 AI 市场：按地区划分

  • 北美
    • 按国家/地区划分的北美癌症诊断 AI 市场
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美地区
  • 欧洲
    • 欧洲癌症诊断 AI 市场：按国家/地区分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲
  • 亚太地区
    • 亚太地区癌症诊断人工智能市场：按国家/地区分类
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • 拉美
    • LAMEA 癌症诊断人工智能市场：按国家/地区分类
      • 巴西
      • 阿根廷
      • 阿联酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 拉美其他地区

第八章公司简介

  • Microsoft Corporation
  • Flatiron Health（F. Hoffmann-La Roche Ltd.）
  • Paige AI, Inc.
  • PathAI, Inc.
  • Therapixel
  • Tempus, Inc.
  • SkinVision BV
  • Cancer Center Sp. z o.o
  • Medial EarlySign
  • Kheiron Medical Technologies Limited

The Global AI In Cancer Diagnostics Market size is expected to reach $509 million by 2028, rising at a market growth of 28.6% CAGR during the forecast period.

Artificial intelligence is an algorithm or computer program that utilizes data or information to make predictions and conclusions. To develop an algorithm, developers have created a bunch of rules or guidelines for the computer to follow the rules and commands. For an instant, Dr. Turkbey along with his team leveraged the current rules about prostate cancer that showed up on the MRI scan machine.

With the help of the machine crew utilized thousands of MRI research in their algorithm, which concluded many people has prostate cancer whereas many of them didn't have any signs of cancer. The algorithm enrolls in how to evaluate and understand data while utilizing machine learning or artificial intelligence. Machine learning may utilize data that are not visible to the human brain or eyes.

Moreover, these algorithms keep on updating and being informed as they are exposed to new data. Deep learning along with machine learning and AI in the detection of cancer. It also utilizes Artificial neural networks which replicate how the human brain collects, analyzes, and reacts to the signals from the entire body. Researchers in NCI's intramural research program is utilizing the complete abilities of AI to enhance cancer testing in prostate and cervical cancer.

15 years ago, NCI physicians started executing biopsies backed by Magnetic resonance imaging, allowing researchers to target the areas of the prostate which could be cancerous. MRI biopsy enhanced the detection and treatment performed by prostate cancer professionals. Moreover, AI helps clinicians to record their diagnostic skills as well as makes algorithms available for clinics across the nation to assist with clinical diagnostics and decision-making.

COVID - 19 Impact Analysis

The coronavirus had a positive impact on AI in the cancer diagnostic market. The implementation of the AI and machine learning assisted to reduce the workload of the health care and clinical facilities. With the growth of the industry, many international IT juggernauts have stepped with to develop AI tools and software to identify the coronavirus which would later help in detecting cancer symptoms. The shortage of healthcare professionals due to the coronavirus cases drives the adoption of AI solutions for better patient assistance and results. The diagnosis, aftercare, and other procedure were hard to maintain during the pandemic as they were time-consuming.

Market Growth Factors

Increasing technological advancements in the healthcare sector

The technologies and the adoption of artificial intelligence in the detection of cancer diagnostics propel the growth of the healthcare sector. The artificial tools contain the need for low-price diagnostic procedures and quick detection data generation. The demand for technology developments in the healthcare sector for detecting and screening cancer is also anticipated to support industry growth. Moreover, the technological enhancement in healthcare by government spending drives the growth of the health care sectors in emerging nations.

Growing need for early cancer diagnosis

The growing awareness of early cancer diagnostics drives the growth of AI in cancer diagnostics. The rise in the number of government programs to promote healthcare organizations along with healthcare providers to combine AI technologies in their hospitals for the betterment and advance the therapy of the patients. Moreover, the adoption of the technologies helps private organizations and nonprofit organizations to deliver enhanced medical results and the reduced cost of treatment which increases early diagnostic among people.

Market Restraining Factors

Lack of Understanding of AI Use in the Healthcare Sector

Managing huge datasets and databases along with the knowledge & training of AI systems and machine learning is the biggest barrier to deep learning technologies. However, the utilization of AI can also bring the issue of data breaches because it could provide crucial individual data such as genomic sequences. The various issues restricting the growth include the lack of transparency, risk of bias for the AI algorithms, data utilized for training purposes, and problem encounters while AI implementation authority in clinical settings. Philosophical issues are one of the thorniest problems faced in artificial intelligence.

End-User Outlook

By End-user, the AI in Cancer Diagnostics Market is classified into Hospital, Surgical Centers and Medical Institutes, and Others. The surgical centers & medical institutes segment registered a remarkable revenue share in the AI in cancer diagnostics market in 2021. It is because the adoption of AI has reduced the cases of misleading negatives and positives to deliver enhanced patient results. The evolution of medical education is propelling along with the growth of healthcare. Moreover, the adoption and practice of medicine with the implementation of AI and the utilization of data learning for better invention enhance the growth and decision making in the industry.

Component Outlook

Based on the Component, the AI in Cancer Diagnostics Market is segmented into Software Solutions Hardware, and Services. The software solutions segment acquired the highest revenue share in the AI in cancer diagnostics market in 2021. It is because many big competitors are launching new solutions for the diagnosis of cancer. With the help of the software, doctors can efficiently and precisely identify the micro size of cancer or tumor. Moreover, artificial intelligence software is more precise and trustworthy than the human diagnostic system. The software platform provides high-quality analytics, and quick results grow the confidence of the doctors as well as boost productivity along with human safety.

Cancer Type Outlook

On the basis of Cancer Type, the AI in Cancer Diagnostics Market is divided into Breast Cancer, Lung Cancer, Prostate & Colorectal Cancer, Brain Tumor, Skin Cancer & Cervical Cancer and Others. The breast cancer segment procured the largest revenue share in the AI in cancer diagnostics market in 2021. It is because the incidence of breast cancer is growing due to the cells in the breast growing out of control. Breast cancer depends on which cell is infected in the breast which came out as cancer. The breast is made up of three components which include ducts, lobules, and connective tissue.

Regional Outlook

Region-wise, the AI in Cancer Diagnostics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment acquired the largest revenue share in the AI in cancer diagnostics market in 2021. The growing cancer prevalence along with the accessibility of the updated healthcare infrastructure propel the growth of the market. However, the increasing government initiatives and the expenditure in the healthcare sector drive the growth of AI in the medical sector. The growing number of patient's diagnostic propels the growth of AI in cancer diagnostics in this region.

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Microsoft Corporation is the forerunner in the AI In Cancer Diagnostics Market. Companies such as Flatiron Health (F. Hoffmann-La Roche Ltd.), Paige AI, Inc., PathAI, Inc. are some of the key innovators in AI In Cancer Diagnostics Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.

Recent Strategies Deployed in AI In Cancer Diagnostics Market

Partnership, Collaboration and Agreement:

Nov-2022: Flatiron Health came into partnership with Caris Life Sciences (Caris), the leading molecular science and technology company. Through this partnership, the company aimed at broadening access to precision medicine at the point of care with seamless ordering and receipt of Caris molecular profiling by integrating OncoEMR platform, a leading cloud-based electronic medical record (EMR) tool.

Aug-2022: PathAI came into partnership with Bristol Myers Squibb, an American multinational pharmaceutical company. Through this partnership, the company aimed at developing drugs by expanding the use of artificial intelligence (AI).

Jan-2022: Flatiron Health joined hands with NCCHE, a Japanese cancer center that provides cancer medicine. The collaboration is aimed at expanding the company's international presence.

Nov-2021: Kheiron Medical Technologies teamed up with Stanford University, a private research university. This collaboration aimed at using the expertise of the Stanford Center for Artificial Intelligence in Medicine & Imaging to enhance the use of AI in new areas of Oncology.

Oct-2021: PathAI came into partnership with Roche, a biotechnology company that develops and provides drugs and diagnostics. Through this partnership, the company aimed at developing and providing its AI pathology through Roche's uPath enterprise software.

Jun-2021: Kheiron Medical Technologies entered into a partnership with Atlas Medical, a manufacturer and supplier of quality Diagnostic Reagents and Kits. The partnership is aimed at launching Mia, a solution for breast cancer screening that supports radiologists in detecting cancer more accurately.

May-2021: Paige joined hands with Quest Diagnostics, an American clinical laboratory that provides diagnostic insights. Through this collaboration, the company aimed at delivering faster, more accurate, and more informed clinical insights by creating new software.

Mar-2021: Paige came into partnership with Epredia, a global leader in precision cancer diagnostics. Through this partnership, the company aimed at helping pathologists to unlock insights from each sample and provide results to the patient and clinician more quickly by offering a portfolio of software.

Dec-2020: Tempus joined hands with Bayer, a German multinational pharmaceutical and biotechnology company. The collaboration aimed at providing genomic testing access and tailored treatment approaches for the oncology community.

Product Launch and Product Expansion:

May-2022: Therapixel launched MammoScreen - 2D and 3D, an AI-based software that automatically analyzes mammograms and displays a summary report to radiologists, providing breast cancer detection and using prior exams to refine prediction.

Mar-2022: Paige unveiled Paige Breast Lymph Node, an AI medical device software, designed to increase the accuracy and efficiency in the detection of breast cancer. The launch focused on helping pathologists detecting if breast cancer has metastasized to lymph nodes.

Acquisition, Joint Venture and Merger:

Jul-2021: PathAI completed the acquisition of Poplar, the management service organization for Poplar Healthcare PLLC, an industry-leading independent anatomic pathology laboratory services provider. Through this acquisition, the company would be able to integrate testing services into its existing artificial intelligence-powered pathology platform.

Scope of the Study

Market Segments covered in the Report:

By End-user

  • Hospital
  • Surgical Centers & Medical Institutes
  • Others

By Component

  • Software Solutions
  • Hardware
  • Services

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Brain Tumor
  • Skin Cancer & Cervical Cancer
  • Prostate & Colorectal Cancer
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Microsoft Corporation
  • Flatiron Health
  • Paige AI, Inc.
  • PathAI, Inc.
  • Therapixel
  • Tempus, Inc.
  • SkinVision BV
  • Cancer Center Sp. z o.o.
  • Medial EarlySign
  • Kheiron Medical Technologies Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global AI In Cancer Diagnostics Market, by End-user
    • 1.4.2 Global AI In Cancer Diagnostics Market, by Component
    • 1.4.3 Global AI In Cancer Diagnostics Market, by Cancer Type
    • 1.4.4 Global AI In Cancer Diagnostics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players

Chapter 4. Global AI In Cancer Diagnostics Market by End-user

  • 4.1 Global Hospital Market by Region
  • 4.2 Global Surgical Centers & Medical Institutes Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global AI In Cancer Diagnostics Market by Component

  • 5.1 Global Software Solutions Market by Region
  • 5.2 Global Hardware Market by Region
  • 5.3 Global Services Market by Region

Chapter 6. Global AI In Cancer Diagnostics Market by Cancer Type

  • 6.1 Global Breast Cancer Market by Region
  • 6.2 Global Lung Cancer Market by Region
  • 6.3 Global Brain Tumor Market by Region
  • 6.4 Global Skin Cancer & Cervical Cancer Market by Region
  • 6.5 Global Prostate & Colorectal Cancer Market by Region
  • 6.6 Global Others Market by Region

Chapter 7. Global AI In Cancer Diagnostics Market by Region

  • 7.1 North America AI In Cancer Diagnostics Market
    • 7.1.1 North America AI In Cancer Diagnostics Market by End-user
      • 7.1.1.1 North America Hospital Market by Country
      • 7.1.1.2 North America Surgical Centers & Medical Institutes Market by Country
      • 7.1.1.3 North America Others Market by Country
    • 7.1.2 North America AI In Cancer Diagnostics Market by Component
      • 7.1.2.1 North America Software Solutions Market by Country
      • 7.1.2.2 North America Hardware Market by Country
      • 7.1.2.3 North America Services Market by Country
    • 7.1.3 North America AI In Cancer Diagnostics Market by Cancer Type
      • 7.1.3.1 North America Breast Cancer Market by Country
      • 7.1.3.2 North America Lung Cancer Market by Country
      • 7.1.3.3 North America Brain Tumor Market by Country
      • 7.1.3.4 North America Skin Cancer & Cervical Cancer Market by Country
      • 7.1.3.5 North America Prostate & Colorectal Cancer Market by Country
      • 7.1.3.6 North America Others Market by Country
    • 7.1.4 North America AI In Cancer Diagnostics Market by Country
      • 7.1.4.1 US AI In Cancer Diagnostics Market
        • 7.1.4.1.1 US AI In Cancer Diagnostics Market by End-user
        • 7.1.4.1.2 US AI In Cancer Diagnostics Market by Component
        • 7.1.4.1.3 US AI In Cancer Diagnostics Market by Cancer Type
      • 7.1.4.2 Canada AI In Cancer Diagnostics Market
        • 7.1.4.2.1 Canada AI In Cancer Diagnostics Market by End-user
        • 7.1.4.2.2 Canada AI In Cancer Diagnostics Market by Component
        • 7.1.4.2.3 Canada AI In Cancer Diagnostics Market by Cancer Type
      • 7.1.4.3 Mexico AI In Cancer Diagnostics Market
        • 7.1.4.3.1 Mexico AI In Cancer Diagnostics Market by End-user
        • 7.1.4.3.2 Mexico AI In Cancer Diagnostics Market by Component
        • 7.1.4.3.3 Mexico AI In Cancer Diagnostics Market by Cancer Type
      • 7.1.4.4 Rest of North America AI In Cancer Diagnostics Market
        • 7.1.4.4.1 Rest of North America AI In Cancer Diagnostics Market by End-user
        • 7.1.4.4.2 Rest of North America AI In Cancer Diagnostics Market by Component
        • 7.1.4.4.3 Rest of North America AI In Cancer Diagnostics Market by Cancer Type
  • 7.2 Europe AI In Cancer Diagnostics Market
    • 7.2.1 Europe AI In Cancer Diagnostics Market by End-user
      • 7.2.1.1 Europe Hospital Market by Country
      • 7.2.1.2 Europe Surgical Centers & Medical Institutes Market by Country
      • 7.2.1.3 Europe Others Market by Country
    • 7.2.2 Europe AI In Cancer Diagnostics Market by Component
      • 7.2.2.1 Europe Software Solutions Market by Country
      • 7.2.2.2 Europe Hardware Market by Country
      • 7.2.2.3 Europe Services Market by Country
    • 7.2.3 Europe AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.3.1 Europe Breast Cancer Market by Country
      • 7.2.3.2 Europe Lung Cancer Market by Country
      • 7.2.3.3 Europe Brain Tumor Market by Country
      • 7.2.3.4 Europe Skin Cancer & Cervical Cancer Market by Country
      • 7.2.3.5 Europe Prostate & Colorectal Cancer Market by Country
      • 7.2.3.6 Europe Others Market by Country
    • 7.2.4 Europe AI In Cancer Diagnostics Market by Country
      • 7.2.4.1 Germany AI In Cancer Diagnostics Market
        • 7.2.4.1.1 Germany AI In Cancer Diagnostics Market by End-user
        • 7.2.4.1.2 Germany AI In Cancer Diagnostics Market by Component
        • 7.2.4.1.3 Germany AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.2 UK AI In Cancer Diagnostics Market
        • 7.2.4.2.1 UK AI In Cancer Diagnostics Market by End-user
        • 7.2.4.2.2 UK AI In Cancer Diagnostics Market by Component
        • 7.2.4.2.3 UK AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.3 France AI In Cancer Diagnostics Market
        • 7.2.4.3.1 France AI In Cancer Diagnostics Market by End-user
        • 7.2.4.3.2 France AI In Cancer Diagnostics Market by Component
        • 7.2.4.3.3 France AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.4 Russia AI In Cancer Diagnostics Market
        • 7.2.4.4.1 Russia AI In Cancer Diagnostics Market by End-user
        • 7.2.4.4.2 Russia AI In Cancer Diagnostics Market by Component
        • 7.2.4.4.3 Russia AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.5 Spain AI In Cancer Diagnostics Market
        • 7.2.4.5.1 Spain AI In Cancer Diagnostics Market by End-user
        • 7.2.4.5.2 Spain AI In Cancer Diagnostics Market by Component
        • 7.2.4.5.3 Spain AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.6 Italy AI In Cancer Diagnostics Market
        • 7.2.4.6.1 Italy AI In Cancer Diagnostics Market by End-user
        • 7.2.4.6.2 Italy AI In Cancer Diagnostics Market by Component
        • 7.2.4.6.3 Italy AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.7 Rest of Europe AI In Cancer Diagnostics Market
        • 7.2.4.7.1 Rest of Europe AI In Cancer Diagnostics Market by End-user
        • 7.2.4.7.2 Rest of Europe AI In Cancer Diagnostics Market by Component
        • 7.2.4.7.3 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type
  • 7.3 Asia Pacific AI In Cancer Diagnostics Market
    • 7.3.1 Asia Pacific AI In Cancer Diagnostics Market by End-user
      • 7.3.1.1 Asia Pacific Hospital Market by Country
      • 7.3.1.2 Asia Pacific Surgical Centers & Medical Institutes Market by Country
      • 7.3.1.3 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific AI In Cancer Diagnostics Market by Component
      • 7.3.2.1 Asia Pacific Software Solutions Market by Country
      • 7.3.2.2 Asia Pacific Hardware Market by Country
      • 7.3.2.3 Asia Pacific Services Market by Country
    • 7.3.3 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.3.1 Asia Pacific Breast Cancer Market by Country
      • 7.3.3.2 Asia Pacific Lung Cancer Market by Country
      • 7.3.3.3 Asia Pacific Brain Tumor Market by Country
      • 7.3.3.4 Asia Pacific Skin Cancer & Cervical Cancer Market by Country
      • 7.3.3.5 Asia Pacific Prostate & Colorectal Cancer Market by Country
      • 7.3.3.6 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific AI In Cancer Diagnostics Market by Country
      • 7.3.4.1 China AI In Cancer Diagnostics Market
        • 7.3.4.1.1 China AI In Cancer Diagnostics Market by End-user
        • 7.3.4.1.2 China AI In Cancer Diagnostics Market by Component
        • 7.3.4.1.3 China AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.2 Japan AI In Cancer Diagnostics Market
        • 7.3.4.2.1 Japan AI In Cancer Diagnostics Market by End-user
        • 7.3.4.2.2 Japan AI In Cancer Diagnostics Market by Component
        • 7.3.4.2.3 Japan AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.3 India AI In Cancer Diagnostics Market
        • 7.3.4.3.1 India AI In Cancer Diagnostics Market by End-user
        • 7.3.4.3.2 India AI In Cancer Diagnostics Market by Component
        • 7.3.4.3.3 India AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.4 South Korea AI In Cancer Diagnostics Market
        • 7.3.4.4.1 South Korea AI In Cancer Diagnostics Market by End-user
        • 7.3.4.4.2 South Korea AI In Cancer Diagnostics Market by Component
        • 7.3.4.4.3 South Korea AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.5 Singapore AI In Cancer Diagnostics Market
        • 7.3.4.5.1 Singapore AI In Cancer Diagnostics Market by End-user
        • 7.3.4.5.2 Singapore AI In Cancer Diagnostics Market by Component
        • 7.3.4.5.3 Singapore AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.6 Malaysia AI In Cancer Diagnostics Market
        • 7.3.4.6.1 Malaysia AI In Cancer Diagnostics Market by End-user
        • 7.3.4.6.2 Malaysia AI In Cancer Diagnostics Market by Component
        • 7.3.4.6.3 Malaysia AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.7 Rest of Asia Pacific AI In Cancer Diagnostics Market
        • 7.3.4.7.1 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user
        • 7.3.4.7.2 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component
        • 7.3.4.7.3 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
  • 7.4 LAMEA AI In Cancer Diagnostics Market
    • 7.4.1 LAMEA AI In Cancer Diagnostics Market by End-user
      • 7.4.1.1 LAMEA Hospital Market by Country
      • 7.4.1.2 LAMEA Surgical Centers & Medical Institutes Market by Country
      • 7.4.1.3 LAMEA Others Market by Country
    • 7.4.2 LAMEA AI In Cancer Diagnostics Market by Component
      • 7.4.2.1 LAMEA Software Solutions Market by Country
      • 7.4.2.2 LAMEA Hardware Market by Country
      • 7.4.2.3 LAMEA Services Market by Country
    • 7.4.3 LAMEA AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.3.1 LAMEA Breast Cancer Market by Country
      • 7.4.3.2 LAMEA Lung Cancer Market by Country
      • 7.4.3.3 LAMEA Brain Tumor Market by Country
      • 7.4.3.4 LAMEA Skin Cancer & Cervical Cancer Market by Country
      • 7.4.3.5 LAMEA Prostate & Colorectal Cancer Market by Country
      • 7.4.3.6 LAMEA Others Market by Country
    • 7.4.4 LAMEA AI In Cancer Diagnostics Market by Country
      • 7.4.4.1 Brazil AI In Cancer Diagnostics Market
        • 7.4.4.1.1 Brazil AI In Cancer Diagnostics Market by End-user
        • 7.4.4.1.2 Brazil AI In Cancer Diagnostics Market by Component
        • 7.4.4.1.3 Brazil AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.2 Argentina AI In Cancer Diagnostics Market
        • 7.4.4.2.1 Argentina AI In Cancer Diagnostics Market by End-user
        • 7.4.4.2.2 Argentina AI In Cancer Diagnostics Market by Component
        • 7.4.4.2.3 Argentina AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.3 UAE AI In Cancer Diagnostics Market
        • 7.4.4.3.1 UAE AI In Cancer Diagnostics Market by End-user
        • 7.4.4.3.2 UAE AI In Cancer Diagnostics Market by Component
        • 7.4.4.3.3 UAE AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.4 Saudi Arabia AI In Cancer Diagnostics Market
        • 7.4.4.4.1 Saudi Arabia AI In Cancer Diagnostics Market by End-user
        • 7.4.4.4.2 Saudi Arabia AI In Cancer Diagnostics Market by Component
        • 7.4.4.4.3 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.5 South Africa AI In Cancer Diagnostics Market
        • 7.4.4.5.1 South Africa AI In Cancer Diagnostics Market by End-user
        • 7.4.4.5.2 South Africa AI In Cancer Diagnostics Market by Component
        • 7.4.4.5.3 South Africa AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.6 Nigeria AI In Cancer Diagnostics Market
        • 7.4.4.6.1 Nigeria AI In Cancer Diagnostics Market by End-user
        • 7.4.4.6.2 Nigeria AI In Cancer Diagnostics Market by Component
        • 7.4.4.6.3 Nigeria AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.7 Rest of LAMEA AI In Cancer Diagnostics Market
        • 7.4.4.7.1 Rest of LAMEA AI In Cancer Diagnostics Market by End-user
        • 7.4.4.7.2 Rest of LAMEA AI In Cancer Diagnostics Market by Component
        • 7.4.4.7.3 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type

Chapter 8. Company Profiles

  • 8.1 Microsoft Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 SWOT Analysis
  • 8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Partnerships, Collaborations, and Agreements:
  • 8.3 Paige AI, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Recent strategies and developments:
      • 8.3.2.1 Partnerships, Collaborations, and Agreements:
      • 8.3.2.2 Product Launches and Product Expansions:
  • 8.4 PathAI, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Recent strategies and developments:
      • 8.4.2.1 Partnerships, Collaborations, and Agreements:
      • 8.4.2.2 Acquisition and Mergers:
  • 8.5 Therapixel
    • 8.5.1 Company Overview
    • 8.5.2 Recent strategies and developments:
      • 8.5.2.1 Product Launches and Product Expansions:
  • 8.6 Tempus, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Recent strategies and developments:
      • 8.6.2.1 Partnerships, Collaborations, and Agreements:
  • 8.7 SkinVision BV
    • 8.7.1 Company Overview
  • 8.8 Cancer Center Sp. z o.o.
    • 8.8.1 Company Overview
  • 8.9 Medial EarlySign
    • 8.9.1 Company Overview
  • 8.10. Kheiron Medical Technologies Limited
    • 8.10.1 Company Overview
    • 8.10.2 Recent strategies and developments:
      • 8.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 Global AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 2 Global AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 3 Partnerships, Collaborations and Agreements- AI In Cancer Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions- AI In Cancer Diagnostics Market
  • TABLE 5 Acquisition and Mergers- AI In Cancer Diagnostics Market
  • TABLE 6 Global AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 7 Global AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 8 Global Hospital Market by Region, 2018 - 2021, USD Thousands
  • TABLE 9 Global Hospital Market by Region, 2022 - 2028, USD Thousands
  • TABLE 10 Global Surgical Centers & Medical Institutes Market by Region, 2018 - 2021, USD Thousands
  • TABLE 11 Global Surgical Centers & Medical Institutes Market by Region, 2022 - 2028, USD Thousands
  • TABLE 12 Global Others Market by Region, 2018 - 2021, USD Thousands
  • TABLE 13 Global Others Market by Region, 2022 - 2028, USD Thousands
  • TABLE 14 Global AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 15 Global AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 16 Global Software Solutions Market by Region, 2018 - 2021, USD Thousands
  • TABLE 17 Global Software Solutions Market by Region, 2022 - 2028, USD Thousands
  • TABLE 18 Global Hardware Market by Region, 2018 - 2021, USD Thousands
  • TABLE 19 Global Hardware Market by Region, 2022 - 2028, USD Thousands
  • TABLE 20 Global Services Market by Region, 2018 - 2021, USD Thousands
  • TABLE 21 Global Services Market by Region, 2022 - 2028, USD Thousands
  • TABLE 22 Global AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 23 Global AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 24 Global Breast Cancer Market by Region, 2018 - 2021, USD Thousands
  • TABLE 25 Global Breast Cancer Market by Region, 2022 - 2028, USD Thousands
  • TABLE 26 Global Lung Cancer Market by Region, 2018 - 2021, USD Thousands
  • TABLE 27 Global Lung Cancer Market by Region, 2022 - 2028, USD Thousands
  • TABLE 28 Global Brain Tumor Market by Region, 2018 - 2021, USD Thousands
  • TABLE 29 Global Brain Tumor Market by Region, 2022 - 2028, USD Thousands
  • TABLE 30 Global Skin Cancer & Cervical Cancer Market by Region, 2018 - 2021, USD Thousands
  • TABLE 31 Global Skin Cancer & Cervical Cancer Market by Region, 2022 - 2028, USD Thousands
  • TABLE 32 Global Prostate & Colorectal Cancer Market by Region, 2018 - 2021, USD Thousands
  • TABLE 33 Global Prostate & Colorectal Cancer Market by Region, 2022 - 2028, USD Thousands
  • TABLE 34 Global Others Market by Region, 2018 - 2021, USD Thousands
  • TABLE 35 Global Others Market by Region, 2022 - 2028, USD Thousands
  • TABLE 36 Global AI In Cancer Diagnostics Market by Region, 2018 - 2021, USD Thousands
  • TABLE 37 Global AI In Cancer Diagnostics Market by Region, 2022 - 2028, USD Thousands
  • TABLE 38 North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 39 North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 40 North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 41 North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 42 North America Hospital Market by Country, 2018 - 2021, USD Thousands
  • TABLE 43 North America Hospital Market by Country, 2022 - 2028, USD Thousands
  • TABLE 44 North America Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
  • TABLE 45 North America Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
  • TABLE 46 North America Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 47 North America Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 48 North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 49 North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 50 North America Software Solutions Market by Country, 2018 - 2021, USD Thousands
  • TABLE 51 North America Software Solutions Market by Country, 2022 - 2028, USD Thousands
  • TABLE 52 North America Hardware Market by Country, 2018 - 2021, USD Thousands
  • TABLE 53 North America Hardware Market by Country, 2022 - 2028, USD Thousands
  • TABLE 54 North America Services Market by Country, 2018 - 2021, USD Thousands
  • TABLE 55 North America Services Market by Country, 2022 - 2028, USD Thousands
  • TABLE 56 North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 57 North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 58 North America Breast Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 59 North America Breast Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 60 North America Lung Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 61 North America Lung Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 62 North America Brain Tumor Market by Country, 2018 - 2021, USD Thousands
  • TABLE 63 North America Brain Tumor Market by Country, 2022 - 2028, USD Thousands
  • TABLE 64 North America Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 65 North America Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 66 North America Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 67 North America Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 68 North America Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 69 North America Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 70 North America AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
  • TABLE 71 North America AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
  • TABLE 72 US AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 73 US AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 74 US AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 75 US AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 76 US AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 77 US AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 78 US AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 79 US AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 80 Canada AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 81 Canada AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 82 Canada AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 83 Canada AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 84 Canada AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 85 Canada AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 86 Canada AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 87 Canada AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 88 Mexico AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 89 Mexico AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 90 Mexico AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 91 Mexico AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 92 Mexico AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 93 Mexico AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 94 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 95 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 96 Rest of North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 97 Rest of North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 98 Rest of North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 99 Rest of North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 100 Rest of North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 101 Rest of North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 102 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 103 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 104 Europe AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 105 Europe AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 106 Europe AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 107 Europe AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 108 Europe Hospital Market by Country, 2018 - 2021, USD Thousands
  • TABLE 109 Europe Hospital Market by Country, 2022 - 2028, USD Thousands
  • TABLE 110 Europe Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
  • TABLE 111 Europe Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
  • TABLE 112 Europe Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 113 Europe Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 114 Europe AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 115 Europe AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 116 Europe Software Solutions Market by Country, 2018 - 2021, USD Thousands
  • TABLE 117 Europe Software Solutions Market by Country, 2022 - 2028, USD Thousands
  • TABLE 118 Europe Hardware Market by Country, 2018 - 2021, USD Thousands
  • TABLE 119 Europe Hardware Market by Country, 2022 - 2028, USD Thousands
  • TABLE 120 Europe Services Market by Country, 2018 - 2021, USD Thousands
  • TABLE 121 Europe Services Market by Country, 2022 - 2028, USD Thousands
  • TABLE 122 Europe AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 123 Europe AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 124 Europe Breast Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 125 Europe Breast Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 126 Europe Lung Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 127 Europe Lung Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 128 Europe Brain Tumor Market by Country, 2018 - 2021, USD Thousands
  • TABLE 129 Europe Brain Tumor Market by Country, 2022 - 2028, USD Thousands
  • TABLE 130 Europe Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 131 Europe Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 132 Europe Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 133 Europe Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 134 Europe Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 135 Europe Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 136 Europe AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
  • TABLE 137 Europe AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
  • TABLE 138 Germany AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 139 Germany AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 140 Germany AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 141 Germany AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 142 Germany AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 143 Germany AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 144 Germany AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 145 Germany AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 146 UK AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 147 UK AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 148 UK AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 149 UK AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 150 UK AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 151 UK AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 152 UK AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 153 UK AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 154 France AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 155 France AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 156 France AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 157 France AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 158 France AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 159 France AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 160 France AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 161 France AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 162 Russia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 163 Russia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 164 Russia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 165 Russia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 166 Russia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 167 Russia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 168 Russia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 169 Russia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 170 Spain AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 171 Spain AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 172 Spain AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 173 Spain AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 174 Spain AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 175 Spain AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 176 Spain AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 177 Spain AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 178 Italy AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 179 Italy AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 180 Italy AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 181 Italy AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 182 Italy AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 183 Italy AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 184 Italy AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 185 Italy AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 186 Rest of Europe AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 187 Rest of Europe AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 188 Rest of Europe AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 189 Rest of Europe AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 190 Rest of Europe AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 191 Rest of Europe AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 192 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 193 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 194 Asia Pacific AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 195 Asia Pacific AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 196 Asia Pacific AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 197 Asia Pacific AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 198 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Thousands
  • TABLE 199 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Thousands
  • TABLE 200 Asia Pacific Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
  • TABLE 201 Asia Pacific Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
  • TABLE 202 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 203 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 204 Asia Pacific AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 205 Asia Pacific AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 206 Asia Pacific Software Solutions Market by Country, 2018 - 2021, USD Thousands
  • TABLE 207 Asia Pacific Software Solutions Market by Country, 2022 - 2028, USD Thousands
  • TABLE 208 Asia Pacific Hardware Market by Country, 2018 - 2021, USD Thousands
  • TABLE 209 Asia Pacific Hardware Market by Country, 2022 - 2028, USD Thousands
  • TABLE 210 Asia Pacific Services Market by Country, 2018 - 2021, USD Thousands
  • TABLE 211 Asia Pacific Services Market by Country, 2022 - 2028, USD Thousands
  • TABLE 212 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 213 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 214 Asia Pacific Breast Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 215 Asia Pacific Breast Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 216 Asia Pacific Lung Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 217 Asia Pacific Lung Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 218 Asia Pacific Brain Tumor Market by Country, 2018 - 2021, USD Thousands
  • TABLE 219 Asia Pacific Brain Tumor Market by Country, 2022 - 2028, USD Thousands
  • TABLE 220 Asia Pacific Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 221 Asia Pacific Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 222 Asia Pacific Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 223 Asia Pacific Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 224 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 225 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 226 Asia Pacific AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
  • TABLE 227 Asia Pacific AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
  • TABLE 228 China AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 229 China AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 230 China AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 231 China AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 232 China AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 233 China AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 234 China AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 235 China AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 236 Japan AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 237 Japan AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 238 Japan AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 239 Japan AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 240 Japan AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 241 Japan AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 242 Japan AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 243 Japan AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 244 India AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 245 India AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 246 India AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 247 India AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 248 India AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 249 India AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 250 India AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 251 India AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 252 South Korea AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 253 South Korea AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 254 South Korea AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 255 South Korea AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 256 South Korea AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 257 South Korea AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 258 South Korea AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 259 South Korea AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 260 Singapore AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 261 Singapore AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 262 Singapore AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 263 Singapore AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 264 Singapore AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 265 Singapore AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 266 Singapore AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 267 Singapore AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 268 Malaysia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 269 Malaysia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 270 Malaysia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 271 Malaysia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 272 Malaysia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 273 Malaysia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 274 Malaysia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 275 Malaysia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 276 Rest of Asia Pacific AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 277 Rest of Asia Pacific AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 278 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 279 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 280 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 281 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 282 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 283 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 284 LAMEA AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 285 LAMEA AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 286 LAMEA AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 287 LAMEA AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 288 LAMEA Hospital Market by Country, 2018 - 2021, USD Thousands
  • TABLE 289 LAMEA Hospital Market by Country, 2022 - 2028, USD Thousands
  • TABLE 290 LAMEA Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
  • TABLE 291 LAMEA Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
  • TABLE 292 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 293 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 294 LAMEA AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 295 LAMEA AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 296 LAMEA Software Solutions Market by Country, 2018 - 2021, USD Thousands
  • TABLE 297 LAMEA Software Solutions Market by Country, 2022 - 2028, USD Thousands
  • TABLE 298 LAMEA Hardware Market by Country, 2018 - 2021, USD Thousands
  • TABLE 299 LAMEA Hardware Market by Country, 2022 - 2028, USD Thousands
  • TABLE 300 LAMEA Services Market by Country, 2018 - 2021, USD Thousands
  • TABLE 301 LAMEA Services Market by Country, 2022 - 2028, USD Thousands
  • TABLE 302 LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 303 LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 304 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 305 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 306 LAMEA Lung Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 307 LAMEA Lung Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 308 LAMEA Brain Tumor Market by Country, 2018 - 2021, USD Thousands
  • TABLE 309 LAMEA Brain Tumor Market by Country, 2022 - 2028, USD Thousands
  • TABLE 310 LAMEA Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 311 LAMEA Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 312 LAMEA Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 313 LAMEA Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 314 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 315 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 316 LAMEA AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
  • TABLE 317 LAMEA AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
  • TABLE 318 Brazil AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 319 Brazil AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 320 Brazil AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 321 Brazil AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 322 Brazil AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 323 Brazil AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 324 Brazil AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 325 Brazil AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 326 Argentina AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 327 Argentina AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 328 Argentina AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 329 Argentina AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 330 Argentina AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 331 Argentina AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 332 Argentina AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 333 Argentina AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 334 UAE AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 335 UAE AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 336 UAE AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 337 UAE AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 338 UAE AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 339 UAE AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 340 UAE AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 341 UAE AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 342 Saudi Arabia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 343 Saudi Arabia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 344 Saudi Arabia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 345 Saudi Arabia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 346 Saudi Arabia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 347 Saudi Arabia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 348 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 349 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 350 South Africa AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 351 South Africa AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 352 South Africa AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 353 South Africa AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 354 South Africa AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 355 South Africa AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 356 South Africa AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 357 South Africa AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 358 Nigeria AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 359 Nigeria AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 360 Nigeria AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 361 Nigeria AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 362 Nigeria AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 363 Nigeria AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 364 Nigeria AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 365 Nigeria AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 366 Rest of LAMEA AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 367 Rest of LAMEA AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 368 Rest of LAMEA AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 369 Rest of LAMEA AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 370 Rest of LAMEA AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 371 Rest of LAMEA AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 372 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 373 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 374 key information - Microsoft Corporation
  • TABLE 375 Key Information - Flatiron Health
  • TABLE 376 Key Information -Paige AI, Inc.
  • TABLE 377 Key Information - PathAI, Inc.
  • TABLE 378 Key Information -Therapixel
  • TABLE 379 Key Information - Tempus, Inc.
  • TABLE 380 Key Information - SkinVision BV
  • TABLE 381 Key Information - Cancer Center Sp. z o.o.
  • TABLE 382 Key Information - Medial EarlySign
  • TABLE 383 Key Information - Kheiron Medical Technologies Limited

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
  • FIG 5 Global AI In Cancer Diagnostics Market Share by End-user, 2021
  • FIG 6 Global AI In Cancer Diagnostics Market Share by End-user, 2028
  • FIG 7 Global AI In Cancer Diagnostics Market by End-user, 2018 - 2028, USD Thousands
  • FIG 8 Global AI In Cancer Diagnostics Market Share by Component, 2021
  • FIG 9 Global AI In Cancer Diagnostics Market Share by Component, 2028
  • FIG 10 Global AI In Cancer Diagnostics Market by Component, 2018 - 2028, USD Thousands
  • FIG 11 Global AI In Cancer Diagnostics Market Share by Cancer Type, 2021
  • FIG 12 Global AI In Cancer Diagnostics Market Share by Cancer Type, 2028
  • FIG 13 Global AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2028, USD Thousands
  • FIG 14 Global AI In Cancer Diagnostics Market Share by Region, 2021
  • FIG 15 Global AI In Cancer Diagnostics Market Share by Region, 2028
  • FIG 16 Global AI In Cancer Diagnostics Market by Region, 2018 - 2028, USD Thousands
  • FIG 17 SWOT Analysis: Microsoft Corporation
  • FIG 18 Recent strategies and developments: Paige AI, Inc.
  • FIG 19 Recent strategies and developments: PathAI, Inc.